Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-07-07 Sale | 2021-07-09 4:30 pm | Trillium Therapeutics Inc. | TRIL | Uger Robert Chief Scientific Officer | 3,646 | $9 | $32,814 | 102,083 (Direct) | View |
| 2021-06-07 Sale | 2021-06-09 4:23 pm | Trillium Therapeutics Inc. | TRIL | Uger Robert Chief Scientific Officer | 3,646 | $8.27 | $30,152 | 105,729 (Direct) | View |
| 2021-05-07 Sale | 2021-05-11 4:24 pm | Trillium Therapeutics Inc. | TRIL | Uger Robert Chief Scientific Officer | 3,646 | $9.3 | $33,908 | 109,375 (Direct) | View |
| 2021-04-07 Sale | 2021-04-09 5:38 pm | Trillium Therapeutics Inc. | TRIL | Uger Robert Chief Scientific Officer | 3,646 | $10.82 | $39,450 | 113,021 (Direct) | View |
| 2021-03-12 Sale | 2021-03-15 5:12 pm | Trillium Therapeutics Inc. | TRIL | Uger Robert Chief Scientific Officer | 2,917 | $11.97 | $34,916 | 58,333 (Direct) | View |
| 2021-03-08 Sale | 2021-03-10 5:57 pm | Trillium Therapeutics Inc. | TRIL | Uger Robert Chief Scientific Officer | 3,646 | $10.11 | $36,861 | 116,667 (Direct) | View |
| 2021-02-08 Sale | 2021-02-10 7:18 pm | Trillium Therapeutics Inc. | TRIL | Uger Robert Chief Scientific Officer | 7,147 | $12.77 | $91,270 | 186,823 (Direct) | View |
| 2021-01-11 Sale | 2021-01-13 4:12 pm | Trillium Therapeutics Inc. | TRIL | Uger Robert Chief Scientific Officer | 584 | $15.2 | $8,879 | 5,844 (Direct) | View |
| 2021-01-08 Sale | 2021-01-12 4:11 pm | Trillium Therapeutics Inc. | TRIL | Uger Robert Chief Scientific Officer | 8,517 | $15.71 | $133,806 | 87,640 (Direct) | View |
| 2021-01-07 Sale | 2021-01-11 4:17 pm | Trillium Therapeutics Inc. | TRIL | Uger Robert Chief Scientific Officer | 3,646 | $14.75 | $53,782 | 123,959 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2021-11-17 Disposition | 2021-11-19 1:23 pm | N/A 2029-11-07 | Trillium Therapeutics Inc. | TRIL | Uger Robert Chief Scientific Officer | 468,222 | $0 | 0 (Direct) | View |
| 2021-07-07 Exercise | 2021-07-09 4:30 pm | N/A N/A | Trillium Therapeutics Inc. | TRIL | Uger Robert Chief Scientific Officer | 3,646 | $0.3039 | 102,083 (Direct) | View |
| 2021-07-07 Exercise | 2021-07-09 4:30 pm | N/A 2029-11-07 | Trillium Therapeutics Inc. | TRIL | Uger Robert Chief Scientific Officer | 3,646 | $0 | 102,083 (Direct) | View |
| 2021-06-07 Exercise | 2021-06-09 4:23 pm | N/A 2029-11-07 | Trillium Therapeutics Inc. | TRIL | Uger Robert Chief Scientific Officer | 3,646 | $0 | 105,729 (Direct) | View |
| 2021-06-07 Exercise | 2021-06-09 4:23 pm | N/A N/A | Trillium Therapeutics Inc. | TRIL | Uger Robert Chief Scientific Officer | 3,646 | $0.315 | 105,729 (Direct) | View |
| 2021-05-07 Exercise | 2021-05-11 4:24 pm | N/A N/A | Trillium Therapeutics Inc. | TRIL | Uger Robert Chief Scientific Officer | 3,646 | $0.313 | 109,375 (Direct) | View |
| 2021-05-07 Exercise | 2021-05-11 4:24 pm | N/A 2029-11-07 | Trillium Therapeutics Inc. | TRIL | Uger Robert Chief Scientific Officer | 3,646 | $0 | 109,375 (Direct) | View |
| 2021-04-07 Exercise | 2021-04-09 5:38 pm | N/A N/A | Trillium Therapeutics Inc. | TRIL | Uger Robert Chief Scientific Officer | 3,646 | $0.3012 | 113,021 (Direct) | View |
| 2021-04-07 Exercise | 2021-04-09 5:38 pm | N/A 2029-11-07 | Trillium Therapeutics Inc. | TRIL | Uger Robert Chief Scientific Officer | 3,646 | $0 | 113,021 (Direct) | View |
| 2021-03-12 Exercise | 2021-03-15 5:12 pm | N/A 2028-11-08 | Trillium Therapeutics Inc. | TRIL | Uger Robert Chief Scientific Officer | 2,917 | $0 | 58,333 (Direct) | View |
| 2021-03-12 Exercise | 2021-03-15 5:12 pm | N/A N/A | Trillium Therapeutics Inc. | TRIL | Uger Robert Chief Scientific Officer | 2,917 | $3.3924 | 58,333 (Direct) | View |
| 2021-03-08 Exercise | 2021-03-10 5:57 pm | N/A 2029-11-07 | Trillium Therapeutics Inc. | TRIL | Uger Robert Chief Scientific Officer | 3,646 | $0 | 116,667 (Direct) | View |
| 2021-03-08 Exercise | 2021-03-10 5:57 pm | N/A N/A | Trillium Therapeutics Inc. | TRIL | Uger Robert Chief Scientific Officer | 3,646 | $0.2999 | 116,667 (Direct) | View |
| 2021-02-08 Exercise | 2021-02-10 7:18 pm | N/A N/A | Trillium Therapeutics Inc. | TRIL | Uger Robert Chief Scientific Officer | 2,917 | $3.3137 | 186,823 (Direct) | View |
| 2021-02-09 Exercise | 2021-02-10 7:18 pm | N/A N/A | Trillium Therapeutics Inc. | TRIL | Uger Robert Chief Scientific Officer | 584 | $9.6213 | 186,823 (Direct) | View |
| 2021-02-08 Exercise | 2021-02-10 7:18 pm | N/A 2029-11-07 | Trillium Therapeutics Inc. | TRIL | Uger Robert Chief Scientific Officer | 7,147 | $0 | 186,823 (Direct) | View |
| 2021-02-08 Exercise | 2021-02-10 7:18 pm | N/A N/A | Trillium Therapeutics Inc. | TRIL | Uger Robert Chief Scientific Officer | 3,646 | $0.2977 | 186,823 (Direct) | View |
| 2021-01-11 Exercise | 2021-01-13 4:12 pm | N/A N/A | Trillium Therapeutics Inc. | TRIL | Uger Robert Chief Scientific Officer | 584 | $9.5671 | 5,844 (Direct) | View |
| 2021-01-11 Exercise | 2021-01-13 4:12 pm | N/A 2027-11-09 | Trillium Therapeutics Inc. | TRIL | Uger Robert Chief Scientific Officer | 584 | $0 | 5,844 (Direct) | View |
| 2021-01-08 Exercise | 2021-01-12 4:11 pm | N/A N/A | Trillium Therapeutics Inc. | TRIL | Uger Robert Chief Scientific Officer | 2,917 | $3.331 | 87,640 (Direct) | View |
| 2021-01-08 Exercise | 2021-01-12 4:11 pm | N/A 2026-05-27 | Trillium Therapeutics Inc. | TRIL | Uger Robert Chief Scientific Officer | 8,517 | $0 | 87,640 (Direct) | View |
| 2021-01-08 Exercise | 2021-01-12 4:11 pm | N/A N/A | Trillium Therapeutics Inc. | TRIL | Uger Robert Chief Scientific Officer | 5,600 | $11.01 | 87,640 (Direct) | View |
| 2021-01-07 Exercise | 2021-01-11 4:17 pm | N/A 2029-11-07 | Trillium Therapeutics Inc. | TRIL | Uger Robert Chief Scientific Officer | 3,646 | $0 | 123,959 (Direct) | View |
| 2021-01-07 Exercise | 2021-01-11 4:17 pm | N/A N/A | Trillium Therapeutics Inc. | TRIL | Uger Robert Chief Scientific Officer | 3,646 | $0.2987 | 123,959 (Direct) | View |
Ownership | 2021-01-04 8:19 pm | N/A 2030-12-23 | Trillium Therapeutics Inc. | TRIL | Uger Robert Chief Scientific Officer | 0 | $0 | 509,263 (Direct) | View |